Search research articles
Contact Us
Filters
Showing results (1-10 of 251) with videos related to
Page
of 26
Sort By:
Urologic Oncology
|
December 10, 2014
Commentary on "Optimal schedule of bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies." Zhu S, Tang Y, Li K, Shang Z, Jiang N, Nian X, Sun L, Niu Y, Department of Urology Tianjin Institute of Urology, 2nd Hospital of Tianjin Medical University, People's Republic of China.: BMC Cancer 2013; 13:332. doi:10.1186/1471-2407-13-332
William A See
Reviews in Urology
|
September 21, 2006
Bicalutamide adjuvant to radical prostatectomy
William A See
European Urology
|
April 4, 2012
Words of wisdom. Re: Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials
William A See
The Journal of Urology
|
September 1, 1993
Plasminogen activators: regulators of tumor cell adherence to sites of lower urinary tract surgical trauma
W A See
Clinical & Experimental Metastasis
|
March 1, 1992
Intravesical recombinant tissue plasminogen activator for the prevention of implantation-mediated bladder tumor recurrence
W A See
Urologic Oncology
|
June 26, 2013
Commentary on "Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition." Ros MM, Bueno de Mesquita HB, Kampman E, Aben KK, Büchner FL, Jansen EH, van Gils CH, Egevad L, Overvad K, Tjønneland A, Roswall N, Boutron Ruault MC, Kvaskoff M, Perquier F, Kaaks R, Chang Claude J, Weikert S, Boeing H, Trichopoulou A, Lagiou P, Dilis V, Palli D, Pala V, Sacerdote C, Tumino R, Panico S, Peeters PH, Gram IT, Skeie G, Huerta JM, Barricarte A, Quirós JR, Sánchez MJ, Buckland G, Larrañaga N, Ehrnström R, Wallström P, Ljungberg B, Hallmans G, Key TJ, Allen NE, Khaw KT, Wareham N, Brennan P, Riboli E, Kiemeney LA, National Institute for Public Health and the Environment, Bilthoven, Netherlands: Am J Clin Nutr 2012;96(4):902-10 [Epub 2012 Sep 5]
William A See
Urologic Oncology
|
June 26, 2013
Commentary on "The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature." Swietek N, Waldert M, Rom M, Schatzl G, Wiener HG, Susani M, Klatte T. Department of Urology, Medical University of Vienna, Vienna, Austria: J Urol 2012;188(3):748-53 [Epub 2012 Jul 20]
William A See
Current Treatment Options in Oncology
|
August 28, 2003
Adjuvant hormone therapy after radiation or surgery for localized or locally advanced prostate cancer
William A See
Urology
|
February 25, 2000
Distal ureteral regeneration after radical transurethral bladder tumor resection
W A See
Urologic Oncology
|
June 26, 2013
Commentary on "A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin." Kowalski M, Guindon J, Brazas L, Moore C, Entwistle J, Cizeau J, Jewett MA, MacDonald GC: J Urol 2012;188(5):1712-8 [Epub 2012 Sep 19]
William A See
Page
of 26
Search research articles
Search
Showing results (1-10 of 251) with videos related to
Sort By:
Page
of 26
Urologic Oncology
|
December 10, 2014
Commentary on "Optimal schedule of bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies." Zhu S, Tang Y, Li K, Shang Z, Jiang N, Nian X, Sun L, Niu Y, Department of Urology Tianjin Institute of Urology, 2nd Hospital of Tianjin Medical University, People's Republic of China.: BMC Cancer 2013; 13:332. doi:10.1186/1471-2407-13-332
William A See
Reviews in Urology
|
September 21, 2006
Bicalutamide adjuvant to radical prostatectomy
William A See
European Urology
|
April 4, 2012
Words of wisdom. Re: Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials
William A See
The Journal of Urology
|
September 1, 1993
Plasminogen activators: regulators of tumor cell adherence to sites of lower urinary tract surgical trauma
W A See
Clinical & Experimental Metastasis
|
March 1, 1992
Intravesical recombinant tissue plasminogen activator for the prevention of implantation-mediated bladder tumor recurrence
W A See
Urologic Oncology
|
June 26, 2013
Commentary on "Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition." Ros MM, Bueno de Mesquita HB, Kampman E, Aben KK, Büchner FL, Jansen EH, van Gils CH, Egevad L, Overvad K, Tjønneland A, Roswall N, Boutron Ruault MC, Kvaskoff M, Perquier F, Kaaks R, Chang Claude J, Weikert S, Boeing H, Trichopoulou A, Lagiou P, Dilis V, Palli D, Pala V, Sacerdote C, Tumino R, Panico S, Peeters PH, Gram IT, Skeie G, Huerta JM, Barricarte A, Quirós JR, Sánchez MJ, Buckland G, Larrañaga N, Ehrnström R, Wallström P, Ljungberg B, Hallmans G, Key TJ, Allen NE, Khaw KT, Wareham N, Brennan P, Riboli E, Kiemeney LA, National Institute for Public Health and the Environment, Bilthoven, Netherlands: Am J Clin Nutr 2012;96(4):902-10 [Epub 2012 Sep 5]
William A See
Urologic Oncology
|
June 26, 2013
Commentary on "The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature." Swietek N, Waldert M, Rom M, Schatzl G, Wiener HG, Susani M, Klatte T. Department of Urology, Medical University of Vienna, Vienna, Austria: J Urol 2012;188(3):748-53 [Epub 2012 Jul 20]
William A See
Current Treatment Options in Oncology
|
August 28, 2003
Adjuvant hormone therapy after radiation or surgery for localized or locally advanced prostate cancer
William A See
Urology
|
February 25, 2000
Distal ureteral regeneration after radical transurethral bladder tumor resection
W A See
Urologic Oncology
|
June 26, 2013
Commentary on "A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin." Kowalski M, Guindon J, Brazas L, Moore C, Entwistle J, Cizeau J, Jewett MA, MacDonald GC: J Urol 2012;188(5):1712-8 [Epub 2012 Sep 19]
William A See
Page
of 26